BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Term Trust (NYSE:BMEZ) saw a significant increase in short interest in November. As of November 15th, there was short interest totalling 63,000 shares, an increase of 112.8% from the October 31st total of 29,600 shares. Based on an average trading volume of 216,800 shares, the short-interest ratio is currently 0.3 days.

BlackRock Health Sciences Term Trust Stock Up 0.6 %

Shares of BMEZ traded up 0.10 during trading hours on Friday, reaching 15.66. 215,700 shares of the stock traded hands, compared to its average volume of 267,616. BlackRock Health Sciences Term Trust has a 52 week low of 13.82 and a 52 week high of 16.59. The stock has a fifty day simple moving average of 15.65 and a 200 day simple moving average of 15.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were given a dividend of $0.1769 per share. The ex-dividend date was Friday, November 15th. This represents a $2.12 annualized dividend and a dividend yield of 13.56%.

Insider Transactions at BlackRock Health Sciences Term Trust

In related news, major shareholder Saba Capital Management, L.P. acquired 29,795 shares of the company’s stock in a transaction on Wednesday, October 16th. The shares were acquired at an average cost of 15.81 per share, for a total transaction of 471,058.95. Following the purchase, the insider now owns 20,750,913 shares in the company, valued at approximately 328,071,934.53. The trade was a 0.14 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders acquired a total of 99,630 shares of company stock valued at $1,585,113 over the last three months.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Several institutional investors have recently modified their holdings of the business. K2 Principal Fund L.P. purchased a new position in shares of BlackRock Health Sciences Term Trust in the 3rd quarter worth about $158,000. Jane Street Group LLC bought a new stake in BlackRock Health Sciences Term Trust in the third quarter worth about $357,000. Stifel Financial Corp grew its position in shares of BlackRock Health Sciences Term Trust by 2.2% during the 3rd quarter. Stifel Financial Corp now owns 414,346 shares of the company’s stock valued at $6,563,000 after acquiring an additional 8,843 shares during the period. Brown Brothers Harriman & Co. purchased a new stake in shares of BlackRock Health Sciences Term Trust during the 3rd quarter worth approximately $32,000. Finally, Penserra Capital Management LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the 3rd quarter worth approximately $15,390,000.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.